Participatory Genomic Testing Can Effectively Disseminate Cardiovascular Pharmacogenomics Concepts within Federally Qualified Health Centers: A Feasibility Study.
Cardiovascular Disease
Community Health Partnerships
Community-Based Participatory Research
Genomics Research
Participatory Genomics Testing
Pharmacogenomics
Journal
Ethnicity & disease
ISSN: 1945-0826
Titre abrégé: Ethn Dis
Pays: United States
ID NLM: 9109034
Informations de publication
Date de publication:
2020
2020
Historique:
entrez:
10
4
2020
pubmed:
10
4
2020
medline:
2
2
2021
Statut:
epublish
Résumé
We assessed feasibility of an educational program designed to enhance stakeholder knowledge and perceptions of pharmacogenomics at a federally qualified health center (FQHC). FQHCs have a rich history of providing care to the underserved, but often are not represented by studies evaluating cutting-edge concepts. We used a novel educational platform to provide participatory genomic testing and classroom education. We assessed participant knowledge and perceptions using questionnaires between May and July 2018. We partnered with a FQHC affiliated with an academic medical center in Chicago. Using convenience sampling, we recruited 20 providers and 10 community members for a feasibility study. Providers included physicians, physician extenders, community health workers, and patient health navigators. Community members were patients, supporters, and/or FQHC advisory board members. Participants had the option to undergo personal genomic testing. Online educational modules included basic genetics, cardiovascular pharmacogenomics, and personalized medicine. Education concluded in a 2-hour live course with case-based discussions. Our main outcome was testing pilot feasibility. Baseline knowledge and perceptions were compared with post-intervention assessments using descriptive statistics, t tests (or Wilcoxon rank-sum) for continuous variables and chi-squared (or Fisher's exact) for categorical variables. We found that attitudes toward the intervention were positive and remained so after intervention. Our intervention was both feasible and acceptable. Genomics knowledge increased for nearly all participants. We have determined that a pharmacogenomics educational program tailored for an underrepresented community is feasible and acceptable. Outcomes will advise methodology for larger implementation studies.
Identifiants
pubmed: 32269458
doi: 10.18865/ed.30.S1.167
pii: ed.30.S1.167
pmc: PMC7138441
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
167-176Subventions
Organisme : AHRQ HHS
ID : K12 HS019461
Pays : United States
Organisme : NIMHD NIH HHS
ID : U54 MD010723
Pays : United States
Informations de copyright
Copyright © 2020, Ethnicity & Disease, Inc.
Déclaration de conflit d'intérêts
Competing Interests: None declared.
Références
Am J Pharm Educ. 2016 Feb 25;80(1):3
pubmed: 26941429
Am J Med. 2012 Jan;125(1):5-6
pubmed: 22195527
Health Educ Behav. 2006 Aug;33(4):459-69
pubmed: 16769755
OMICS. 2008 Dec;12(4):263-72
pubmed: 19040372
Circulation. 2017 Nov 21;136(21):e393-e423
pubmed: 29061565
Curr Pharm Biotechnol. 2017;18(3):231-241
pubmed: 28117005
Trends Genet. 2016 Jun;32(6):317-320
pubmed: 27117243
J Community Genet. 2017 Jan;8(1):23-34
pubmed: 27822876
JAMA Cardiol. 2017 Oct 1;2(10):1153-1160
pubmed: 28793145
J Health Polit Policy Law. 2009 Jun;34(3):325-59
pubmed: 19451407
Genet Med. 2017 Feb;19(2):157-159
pubmed: 27490116
J Inherit Metab Dis. 2018 May;41(3):571-582
pubmed: 29362952
Nurs Res Pract. 2013;2013:935740
pubmed: 23840949
Lancet. 2013 Aug 31;382(9894):790-6
pubmed: 23755828
Curr Epidemiol Rep. 2017 Mar;4(1):31-37
pubmed: 28255530
JACC Heart Fail. 2014 Dec;2(6):551-7
pubmed: 25306451
Arch Intern Med. 2002 Nov 25;162(21):2458-63
pubmed: 12437405
Genet Med. 2015 Mar;17(3):169-76
pubmed: 25210938
Am J Cardiovasc Drugs. 2013 Jun;13(3):151-62
pubmed: 23579966
Circulation. 2005 Mar 15;111(10):1233-41
pubmed: 15769763
Prog Community Health Partnersh. 2017;11(2):161-165
pubmed: 28736408
Pharmacogenomics. 2015 Jul;16(8):905-11
pubmed: 26067487
J Health Care Poor Underserved. 2010 Aug;21(3):879-97
pubmed: 20693733
PLoS One. 2013 Jul 23;8(7):e68853
pubmed: 23935898
Am J Pharm Educ. 2016 Sep 25;80(7):122
pubmed: 27756930
Pharmacogenomics. 2014 Jan;15(1):39-48
pubmed: 24329189
J Clin Epidemiol. 2011 Aug;64(8):872-7
pubmed: 21330104